Source: International Congress 2015 – Acute lung injury research: are we doing the right things?



Rating:

Share or cite this content

Citations should be made in the following way:
Danny McAuley (Belfast, United Kingdom). Are we wasting money on premature and badly designed clinical trials?. International Congress 2015 – Acute lung injury research: are we doing the right things?

Member's Comments

No comment yet.

Related content which might interest you: What could we learn from ongoing therapeutic trials? Source: ERS Research Seminar Year: 2015 Negative clinical trials in sarcoidosis: failed therapies or flawed study design? Source: Eur Respir J 2014; 44: 1123-1126 Year: 2014 Why are clinical trials in critically-ill respiratory patients relatively uninformative? Source: International Congress 2014 – Ceremony for the ERS Rare Pulmonary Disease Research Award 2014 followed by the symposium "Challenges in endpoints for rare lung diseases" Year: 2014 Do we have enough evidence overall, or should we wait for ongoing trials? Source: International Congress 2014 – From respiratory infections to wheezing: reevaluating the role of vitamin D levels in childhood Year: 2014 Diagnosing asthma in children or adolescents/young adults? It is time for a change! How timing is everything, also in clinical practice Source: Eur Respir J, 56 (5) 2002687; 10.1183/13993003.02687-2020 Year: 2020 Do the current endpoints in IPF clinical trials allow good regulatory decisions to be made? Source: International Congress 2014 – Ceremony for the ERS Rare Pulmonary Disease Research Award 2014 followed by the symposium "Challenges in endpoints for rare lung diseases" Year: 2014 Biomarker-guided clinical decisions: for patients, health economists or neither? Source: Eur Respir J 2013; 42: 895-897 Year: 2013 Considerations of a real life pragmatic clinical trial in adolescent asthma Source: Eur Respir J, 58 (3) 2100461; 10.1183/13993003.00461-2021 Year: 2021 What is at stake? What are the possible gains and risks? Source: Research Seminar 2005 - Tobacco Smoking: Harm Reduction Strategies Year: 2005 How do we know what works? Clinical trial end-points and quality of life assessment Source: Eur Respir Monogr 2018; 81: 99-132 Year: 2018 Does pulmonary rehabilitation work in clinical practice? A review on selection and dropout in randomised controlled trials on pulmonary rehabilitation Source: Annual Congress 2010 - Outcomes and predictors of the sucess of pulmonary rehabilitation in chronic respiratory disease Year: 2010 How are we going to treat IPF patients in the future? Source: Annual Congress 2013 –The future of IPF: current mysteries and challenges Year: 2013 Web-based self-management support after pulmonary rehabilitation of difficult to treat asthma: a randomised controlled trial Source: International Congress 2017 – Techniques to treat asthma Year: 2017 Is poor asthma self-management due to failure to recognise symptoms or failure to act? Novel insights from mining large-scale clinical observational study Source: International Congress 2019 – M-health/e-health II Year: 2019 Should we treat every patient with latent TB? Is there a cost to pay? Source: International Congress 2018 – Tuberculosis transmission and screening strategies Year: 2018 Preschool asthma - have randomised controlled trials provided clarity on management? Source: International Congress 2018 – Infectious agents and childhood asthma Year: 2018 Where and how to educate the COPD patient? – learnings of a multicentre RCT Source: International Congress 2017 – Passive smoking and epidemiology Year: 2017 Missing data in IPF trials: do not let methodological issues undermine a major therapeutic breakthrough Source: Eur Respir J 2015; 46: 607-614 Year: 2015 Treating asthma in developing countries: is this a question of money? Source: Eur Respir J 2005; 26: Suppl. 49, 274s Year: 2005